Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 12, 2005
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancerMaher N Younes, Seungwon Kim, Orhan G Yigitbasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancerF Christopher Holsinger, Dao D Doan, Samar A Jasser, et al.
Cancer Research|June 3, 2005
Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylationMaher Nabil Younes, Orhan Gazi Yigitbasi, Young Wook Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine modelMaria K Gule, Yunyun Chen, Daisuke Sano, et al.
Cancer Research|December 3, 2005
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude ratsDavid E Blask, George C Brainard, Robert T Dauchy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sitesMei Zhao, Daisuke Sano, Curtis R Pickering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancerBradley A Schiff, Andrea B McMurphy, Samar A Jasser, et al.
Head & Neck|October 15, 2013
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cellsJ Hun Hah, Mei Zhao, Curtis R Pickering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2014
Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokersCurtis R Pickering, Jiexin Zhang, David M Neskey, et al.
Molecular Cell|May 27, 2014
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activationGe Zhou, Jiping Wang, Mei Zhao, et al.
Pageof 5